
Thursday, April 08, 2004 11:57:10 AM
TORONTO, ONTARIO--(CCNMatthews - Apr 8, 2004) - Avrom E. Howard,
President and CEO of Odyssey Resources Limited (ODX:TSXV) is
pleased to announce the addition of National Investor Relations
to the Odyssey team. Jonathan Buick will assume the title of
Manager, Investor Relations while Stephen Coates will continue
his role as Manager, Corporate Communications.
National IR will provide full-time shareholder and investor
relations support as well as media relations and strategic market
communications advice. The contract is for an initial period of
one year with total monthly compensation of $8,250 and the
issuance of 100,000 options exercisable at $0.27/share for a
period of five years and subject to securities regulations.
Jonathan Buick joins Odyssey Resources Limited having spent the
last two years with eResearch. While at eResearch, Mr. Buick was
responsible for business development with issuing companies and
institutions as well as communicating with retail investors. For
the last eight years Mr. Buick has acted in various capacities as
a consultant to both private and public companies.
Odyssey Resources Limited is a Canadian public company focused on
exploration for precious and base metals in the Middle East and
Mediterranean Regions.
For more information visit Odyssey's website at:
http://www.odysseyresources.com
The statements made in this Press Release may contain
forward-looking statements that may involve a number of risks and
uncertainties. Actual events or results could differ materially
from the Company's expectations and projections. The TSX Venture
Exchange has neither approved nor disapproved the information
contained in this press release.
-30-
FOR FURTHER INFORMATION PLEASE CONTACT:
Odyssey Resources Limited
John Buckle
Vice President, Marketing and Investor Relations
416-362-6955
jebuckle@odysseyresources.com
www.odysseyresources.com
Ed

Liked By
Spread the love. Be the first to like this post!
Recent ODX News
- Omega Diagnostics Group PLC Holding(s) in Company • UK Regulatory (RNS & others) • 01/27/2023 03:03:00 PM
- Omega Diagnostics Group PLC Director/PDMR Shareholding • UK Regulatory (RNS & others) • 01/27/2023 09:36:00 AM
- Triad hails recovery; Alpha Group profit tops outlook • Alliance News • 01/18/2023 02:54:52 PM
- Team17 to beat expectations; IOG "disappointed" • Alliance News • 01/18/2023 11:09:54 AM
- Omega Diagnostics Group PLC Trading update • UK Regulatory (RNS & others) • 01/18/2023 07:00:00 AM
- Omega Diagnostics Group PLC Holding(s) in Company • UK Regulatory (RNS & others) • 01/16/2023 10:56:00 AM
- Omega Diagnostics has big US opportunity for FoodPrint • Alliance News • 01/06/2023 09:28:47 PM
- Omega Diagnostics receives first FoodPrint order from CLIA lab in US • Alliance News • 01/06/2023 09:42:06 AM
- Omega Diagnostics Group PLC US expansion update • UK Regulatory (RNS & others) • 01/06/2023 07:00:00 AM
- Omega Diagnostics Group PLC Holding(s) in Company • UK Regulatory (RNS & others) • 01/03/2023 12:34:00 PM
- Omega Diagnostics Group PLC Second Price Monitoring Extn • UK Regulatory (RNS & others) • 12/13/2022 04:40:00 PM
- Omega Diagnostics Group PLC Price Monitoring Extension • UK Regulatory (RNS & others) • 12/13/2022 04:35:00 PM
- Omega Diagnostics Group PLC Holding(s) in Company • UK Regulatory (RNS & others) • 12/13/2022 12:01:00 PM
- Omega Diagnostics Group PLC Holding(s) in Company • UK Regulatory (RNS & others) • 11/30/2022 09:35:00 AM
- Omega Diagnostics receives CD4 deferred consideration • Alliance News • 11/25/2022 11:37:36 AM
- Omega Diagnostics Group PLC Receipt of deferred consideration • UK Regulatory (RNS & others) • 11/25/2022 07:00:00 AM
- Omega Diagnostics turns to interim loss but bets on US market • Alliance News • 11/24/2022 11:57:27 AM
- Omega Diagnostics Group PLC Half-year Report • UK Regulatory (RNS & others) • 11/24/2022 07:00:00 AM
- Omega Diagnostics Group PLC Second Price Monitoring Extn • UK Regulatory (RNS & others) • 11/23/2022 04:41:00 PM
- Omega Diagnostics Group PLC Price Monitoring Extension • UK Regulatory (RNS & others) • 11/23/2022 04:36:00 PM
- Omega Diagnostics Group PLC Second Price Monitoring Extn • UK Regulatory (RNS & others) • 11/23/2022 02:05:00 PM
- Omega Diagnostics Group PLC Price Monitoring Extension • UK Regulatory (RNS & others) • 11/23/2022 02:00:00 PM
- Omega Diagnostics Group PLC Holding(s) in Company • UK Regulatory (RNS & others) • 11/18/2022 12:09:00 PM
- Omega Diagnostics Group PLC Second Price Monitoring Extn • UK Regulatory (RNS & others) • 11/16/2022 02:06:00 PM
- Omega Diagnostics Group PLC Price Monitoring Extension • UK Regulatory (RNS & others) • 11/16/2022 02:00:00 PM
1606 Corp Now Trading under Ticker CBDW, Management Announces First Acquisition • CBDW • Jan 27, 2023 11:59 AM
IQST - iQSTEL Reminds Shareholders To Get Their Votes In Before Annual Meeting Next Week On January 31, 2023 • IQST • Jan 26, 2023 9:53 AM
Nextech AR's AI-Powered CAD to Poly Toggle3D Launches Major Technology Advancements • ARWYF • Jan 26, 2023 8:46 AM
UCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023 • UCASU • Jan 26, 2023 7:21 AM
Kaya Holdings, Inc. (OTCQB: KAYS) Launches Fifth Dimension Therapeutics™ to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market • KAYS • Jan 25, 2023 10:53 AM
B2 Digital's B2 SPORTS NETWORK (B2SN) Expands Distribution to Europe, Russia, and Asia with StayLIVE Agreement • BTDG • Jan 25, 2023 10:00 AM